Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
colorectal cancer
Biotech
BMS-backed TORL grabs $158M to march army of ADCs through clinic
For companies exploring the antibody-drug conjugate arena, the interest from Big Pharma and big-pocketed investors appears to be as strong as ever.
James Waldron
Apr 10, 2024 9:35am
Gritstone ground down by phase 2 cancer vaccine fail
Apr 2, 2024 5:09am
Epigenetic cancer drug duo packs punch against colorectal cancer
Apr 1, 2024 3:20pm
Mouth microbe on the move may drive colorectal cancer
Mar 25, 2024 3:30pm
Exact, Guardant tout next-gen colorectal cancer screening tests
Mar 14, 2024 1:27pm
Roche leads Freenome's $254M fundraising for cancer blood tests
Feb 15, 2024 10:27am